Varaico: Literature-Extracted Genetic Variants

Gene:OTC
Variant:p.R277W
Back to variants list

OTC

NM_000531.6:p.R277W

Associated Papers

Clinical and biochemical characteristics of patients with ornithine transcarbamylase deficiency and in silico analysis of OTC gene.

Zhang Y et al.

Orphanet Journal of Rare Diseases, 2025

Liver transplantation in ornithine transcarbamylase deficiency: A retrospective multicentre cohort study.

Seker Yilmaz B et al.

Molecular Genetics and Metabolism Reports, 2023

Newborn ornithine carbamyltransferase deficiency caused by new OTC gene mutations: a report of two cases and review of the literature on phenotype and genotype.

Yu A et al.

Translational Pediatrics, 2023

37969118 (PubMed )
Supplement: tp-12-10-1887-prf.pdf

Pathogenic variants of ornithine transcarbamylase deficiency: Nation-wide study in Japan and literature review.

Kido J et al.

Frontiers in Genetics, 2022

Variants associated with urea cycle disorders in Japanese patients: Nationwide study and literature review.

Kido J et al.

American Journal of Medical Genetics. Part A, 2021

Expanding Role of Proton Magnetic Resonance Spectroscopy: Timely Diagnosis and Treatment Initiation in Partial Ornithine Transcarbamylase Deficiency.

Sen K et al.

Journal of Pediatric Genetics, 2021

Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency.

Lu D et al.

Orphanet Journal of Rare Diseases, 2020

Retrospective evaluations revealed pre-symptomatic citrulline concentrations measured by newborn screening were significantly low in late-onset ornithine transcarbamylase deficiency patients.

Lee T et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry, 2020

Mitochondrial Enzymes of the Urea Cycle Cluster at the Inner Mitochondrial Membrane.

Haskins N et al.

Frontiers in Physiology, 2020

33551825 (PubMed )
Supplement: Data_Sheet_1.zip › SupplementaryData_DataSheet › Supplementary_Tables_S1-S6.xlsx › Table_S4

Urea cycle disorders in Argentine patients: clinical presentation, biochemical and genetic findings.

Silvera-Ruiz SM et al.

Orphanet Journal of Rare Diseases, 2019

Expanded Newborn Screening for Inborn Errors of Metabolism by Tandem Mass Spectrometry in Suzhou, China: Disease Spectrum, Prevalence, Genetic Characteristics in a Chinese Population.

Wang T et al.

Frontiers in Genetics, 2019

Urea cycle disorders in India: clinical course, biochemical and genetic investigations, and prenatal testing.

Bijarnia-Mahay S et al.

Orphanet Journal of Rare Diseases, 2018

Clinical and mutation analysis of 24 Chinese patients with ornithine transcarbamylase deficiency.

Shao Y et al.

Clinical Genetics, 2017

Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.

Choi JH et al.

Journal of Human Genetics, 2015

Computational pipeline to identify and characterize functional mutations in ornithine transcarbamylase deficiency.

Magesh R et al.

3 Biotech, 2014

Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases.

Martín-Hernández E et al.

Orphanet Journal of Rare Diseases, 2014

OTC gene in ornithine transcarbamylase deficiency: clinical course and mutational spectrum in seven Korean patients.

Lee JH et al.

Pediatric Neurology, 2014

Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment.

Cavicchi C et al.

Orphanet Journal of Rare Diseases, 2014

Ornithine carbamoyltransferase deficiency: molecular characterization of 29 families.

Storkanova G et al.

Clinical Genetics, 2013

Characteristics of NO cycle coupling with urea cycle in non-hyperammonemic carriers of ornithine transcarbamylase deficiency.

Nagasaka H et al.

Molecular Genetics and Metabolism, 2013

Ornithine transcarbamylase (OTC) deficiency based on a hemizygous p.R277W mutation causing life-threatening hyperammonemic crisis during treatment for Hodgkin's lymphoma.

Ritter E et al.

Annals of Hematology, 2011

[Clinical and gene mutation analyses of three patients with ornithine carbamoyltransferase deficiency].

Mo WQ et al.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2011

[Analysis of clinical features, biochemical analysis and gene mutations in one Chinese pedigree with neonatal-onset ornithine transcarbamylase deficiency].

Sun WH et al.

Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics, 2011

Mutant alleles associated with late-onset ornithine transcarbamylase deficiency in male patients have recurrently arisen and have been retained in some populations.

Numata S et al.

Journal of Human Genetics, 2010

High-frequency detection of deletions and variable rearrangements at the ornithine transcarbamylase (OTC) locus by oligonucleotide array CGH.

Shchelochkov OA et al.

Molecular Genetics and Metabolism, 2009

Paternal transmission and slow elimination of mutant alleles associated with late-onset ornithine transcarbamylase deficiency in male patients.

Numata S et al.

Journal of Human Genetics, 2008

Identification of novel mutations in the human ornithine transcarbamylase (OTC) gene of Korean patients with OTC deficiency and transient expression of the mutant proteins in vitro.

Kim GH et al.

Human Mutation, 2006

Mutations and polymorphisms in the human ornithine transcarbamylase gene.

Tuchman M et al.

Human Mutation, 2002

Mutation detection in 65 families with a possible diagnosis of ornithine carbamoyltransferase deficiency including 14 novel mutations.

Genet S et al.

Journal of Inherited Metabolic Disease, 2000

Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype.

McCullough BA et al.

American Journal of Medical Genetics, 2000

1.85-A resolution crystal structure of human ornithine transcarbamoylase complexed with N-phosphonacetyl-L-ornithine. Catalytic mechanism and correlation with inherited deficiency.

Shi D et al.

The Journal of Biological Chemistry, 1998

The biochemical and molecular spectrum of ornithine transcarbamylase deficiency.

Tuchman M et al.

Journal of Inherited Metabolic Disease, 1998

The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency.

Matsuda I et al.

American Journal of Medical Genetics, 1997

'Late onset' ornithine transcarbamylase deficiency: function of three purified recombinant mutant enzymes.

Morizono H et al.

Human Molecular Genetics, 1997

Expression, purification and kinetic characterization of wild-type human ornithine transcarbamylase and a recurrent mutant that produces 'late onset' hyperammonaemia.

Morizono H et al.

The Biochemical Journal, 1997

The R40H mutation in a late onset type of human ornithine transcarbamylase deficiency in male patients.

Nishiyori A et al.

Human Genetics, 1997

Asymptomatic and late-onset ornithine transcarbamylase deficiency caused by a A208T mutation: clinical, biochemical and DNA analyses in a four-generation family.

Ausems MG et al.

American Journal of Medical Genetics, 1997

Phenotypic variability in male patients carrying the mutant ornithine transcarbamylase (OTC) allele, Arg40His, ranging from a child with an unfavourable prognosis to an asymptomatic older adult.

Matsuda I et al.

Journal of Medical Genetics, 1996

Relative frequency of mutations causing ornithine transcarbamylase deficiency in 78 families.

Tuchman M et al.

Human Genetics, 1996

The molecular basis of ornithine transcarbamylase deficiency: modelling the human enzyme and the effects of mutations.

Tuchman M et al.

Journal of Medical Genetics, 1995

Ornithine transcarbamylase deficiency: new sites with increased probability of mutation.

Oppliger Leibundgut EO et al.

Human Genetics, 1995

Proportions of spontaneous mutations in males and females with ornithine transcarbamylase deficiency.

Tuchman M et al.

American Journal of Medical Genetics, 1995

Mutations and polymorphisms in the human ornithine transcarbamylase gene: mutation update addendum.

Tuchman M et al.

Human Mutation, 1995

Four newly identified ornithine transcarbamylase (OTC) mutations (D126G, R129H, I172M and W332X) in Japanese male patients with early-onset OTC deficiency.

Matsuura T et al.

Human Mutation, 1994

Four novel gene mutations in five Japanese male patients with neonatal or late onset OTC deficiency: application of PCR-single-strand conformation polymorphisms for all exons and adjacent introns [corrected].

Matsuura T et al.

Human Genetics, 1993

Mutations and polymorphisms in the human ornithine transcarbamylase gene.

Tuchman M

Human Mutation, 1993

1H MRS identifies symptomatic and asymptomatic subjects with partial ornithine transcarbamylase deficiency.

Gropman AL et al.

Molecular Genetics and Metabolism, 0

Antepartum ornithine transcarbamylase deficiency.

Nakajima H et al.

Case Reports in Gastroenterology, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."